Intra-oral Treatment of OLP With Rivelin®-CLO Patches
Status:
Completed
Trial end date:
2019-12-20
Target enrollment:
Participant gender:
Summary
Participants with symptomatic Oral Lichen Planus lesions will be treated with Rivelin®
patches containing either 0, 1, 5, or 20 μg clobetasol per patch. Each participant will apply
up to 6 patches twice daily for 4 weeks.
Phase:
Phase 2
Details
Lead Sponsor:
Dermtreat
Collaborators:
Proinnovera GmbH X-act Cologne Clinical Research GmbH X-act Cologne Research GmbH